Ultra-high purity emamectin benzoate 99.99% successfully developed and produced by Taiyixin Biotechnology

On April 18, 2024, the R&D laboratory of Ningxia Taiyixin Biotechnology Co., Ltd announced successful development and production of China’s ultra-high purity emamectin benzoate, which is of B1a+B1b mass fraction of 99.99% and B1a+B1b ratio of above 250.

Taiyixin Biotechnology is committed to research and development, production and sales of bio fermented antibiotics mainly covering production of abamectin and emamectin benzoate products, having successively developed milky white non-degradable abamectin technical and the patented crystal and high-active emamectin benzoate, with enhanced development of EC, WDG, WSG, SC and ME formulations to fulfill the market demand.

Taiyixin Biotechnology attaches importance to innovation-oriented capacity building and has made medium and long-term research plan which covers integration of the existing technical achievements, as well as the secondary development. After continuous investment in technical innovation enabling achievement of technical breakthroughs, the company has successfully developed and produced China’s ultra-high purity emamectin benzoate 99.99%, marking Taiyixin Biotechnology’s new milestone of pesticide research and production.

As an intelligent manufacturer, Ningxia Taiyixin Biotechnology Co., Ltd adheres to the mission of ″creating social wealth and serving health undertaking;″ follows the ″talent-based, marketing-oriented, research-backed and management-led″ operation guideline; sticks to the ″innovation, cooperation, unison and win-win″ corporate spirit; makes full use of the regional advantages of Ningxia to stress on development of high-tech biological products which are of international advancement and consistent quality, striving to shape a world-class bio fermented antibiotic industry base.